دورية أكاديمية

Sotorasib for previously treated colorectal cancers with KRASG12C mutation (CodeBreaK100): a prespecified analysis of a single-arm, phase 2 trial

التفاصيل البيبلوغرافية
العنوان: Sotorasib for previously treated colorectal cancers with KRASG12C mutation (CodeBreaK100): a prespecified analysis of a single-arm, phase 2 trial
المؤلفون: Fakih, Marwan G *, Kopetz, Scott, Kuboki, Yasutoshi, Kim, Tae Won, Munster, Pamela N, Krauss, John C, Falchook, Gerald S, Han, Sae-Won, Heinemann, Volker, Muro, Kei, Strickler, John H, Hong, David S, Denlinger, Crystal S, Girotto, Gustavo, Lee, Myung-Ah, Henary, Haby, Tran, Qui, Park, Joseph K, Ngarmchamnanrith, Gataree, Prenen, Hans, Price, Timothy J
المصدر: In The Lancet Oncology January 2022 23(1):115-124
قاعدة البيانات: ScienceDirect
الوصف
تدمد:14702045
DOI:10.1016/S1470-2045(21)00605-7